drugset

drugset / Trial / NCT00333021

Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients

NCT00333021 ↗

Phase 3 Completed 127 enrolled GlaxoSmithKline

RandomizedParallel-groupOpen-labelPrevention

Summary

This study is phase 3 study for prevention of VTE in patients with abdominal surgery.

Timeline

Start: 2006-05
Primary completion: —
Completion: 2007-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fondaparinux	Other / unclassified	—	—

Indications